ArticleCureus2025
Early Cessation of Renal Replacement Therapy in Theophylline Toxicity: A Case Report With Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theophylline toxicity often results in severe neurological and cardiovascular complications and may require renal replacement therapy (RRT) in life-threatening situations. However, guidance on when it is safe to discontinue RRT remains limited. We report the case of an 85-year-old woman who developed status epilepticus following theophylline overdose, with a peak serum level of 119.8 mg/L. She was initially hemodynamically unstable and received continuous hemodiafiltration (CHDF). After clinical stabilization and a reduction in serum theophylline to 24.7 mg/L, CHDF was discontinued despite mild tachycardia and low-dose catecholamine use. The patient remained stable without rebound toxicity and recovered uneventfully. This case highlights that early discontinuation of RRT may be feasible even when theophylline levels exceed traditional thresholds, provided there is sustained clinical improvement, including stability despite mild tachycardia and low-dose catecholamine support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.